Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
Did I say anything about other medication?
No?
Why bring it up?
“These other things aren’t a permanent cure either!” Is a lazy response.
The original comment was acting like gold-1s are a cure where traditional weight loss isn’t. The reality is if you go off them, the same thing happens as going off your diet.
They’re a cure for having an uncontrollable appetite, which makes dieting difficult to impossible.
So if you stop taking them, you retain your controlled appetite?
Spoiler: nope.
They’re not a cure for anything.
That’s so pedantic, but yes, they’re a treatment for an uncontrollable appetite. Do you mean to suggest that you’re against medical treatments which are not cures?
It’s not pedantic when the original commenter I was responding to was saying that traditional weight loss wasn’t a permanent cure, for the same reason that gol1s aren’t a cure… but then framing them as a cure.
They’re not permanent and they do have risks associated with them (pancreatitis and GI tract issues iirc,)